Cellular Synthesis of Targeted Ultrasound Molecular Imaging Probe and Its Application in Prostate Cancer Diagnosis
International Journal of Nanomedicine · 2025
DOI: 10.2147/ijn.s561230 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Zhenzhou Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518061, People's …. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Molecular Imaging, Molecular Probes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
The traditional construction of targeted ultrasound molecular imaging probes relies on multistep chemical synthesis strategies, which are time-consuming and inefficient, thereby limiting technological advancements. To address this, we developed a novel genetic engineering approach for biosynthesizing targeted nanoprobes for prostate cancer diagnosis. Materials and Methods: The anti-PSMA nanobody-encoding gene was fused to the C-terminus of the gas vesicle structural protein gene GvpC and cloned into a pBV220 plasmid with a hyperthermia-responsive gene expression circuit. This recombinant plasmid was transformed into E. coli BL21(A1) harboring pET-28a-ΔGvpC-eGVs plasmids to create PSMA-GVs@E. coli genetically engineered bacteria. The probe assembly were involved in two-step gene expression procedure. ΔGvpC-eGVs were first induced by IPTG, followed by temperature-triggered (42°C) production of PSMA-GvpC proteins that spontaneously assembled onto GVs.
Results
The biosynthesized PSMA-eGVs probes exhibited a uniform size (100-200 nm) and demonstrated excellent targeting capability in prostate cancer cells. In vivo studies confirmed effective tumor vascular penetration and specific binding with PSMA-positive tumor cells, resulting in significantly stronger acoustic signals than the non-targeted EGFP-eGVs controls.
Conclusion
This cellular synthesis strategy enables efficient production of targeted ultrasound molecular imaging probes through genetically engineering technology, providing a promising platform for precision cancer diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518061, People's Republic of China.
- Nuclear Medicine Department, Shenzhen Hezheng Hospital, Shenzhen, 518055, People's Republic of China.
- Graduate School, Guangxi University of Chinese Medicine, Nanning, 530200, People's Republic of China.
- State Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, People's Republic of China.
ORCID-Profile: Xiong Shen
Zitieren
APA
Li, Z., Liu, T., Cui, T., Shen, X., Liu, C., & Yan, F. (2025). Cellular Synthesis of Targeted Ultrasound Molecular Imaging Probe and Its Application in Prostate Cancer Diagnosis. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s561230
Vancouver
Li Z, Liu T, Cui T, Shen X, Liu C, Yan F. Cellular Synthesis of Targeted Ultrasound Molecular Imaging Probe and Its Application in Prostate Cancer Diagnosis. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s561230
BibTeX
@article{Li2025,
author = {Li, Zhenzhou and Liu, Tingting and Cui, Tao and Shen, Xiong and Liu, Chenxing and Yan, Fei},
title = {Cellular Synthesis of Targeted Ultrasound Molecular Imaging Probe and Its Application in Prostate Cancer Diagnosis},
journal = {International Journal of Nanomedicine},
year = {2025},
doi = {10.2147/ijn.s561230}
}
EUVIMED